Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Nov 28;194(46):E1560–E1567. doi: 10.1503/cmaj.221232

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 CMA Impact Inc. or its licensors

This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY-NC-ND 4.0) licence, which permits use, distribution and reproduction in any medium, provided that the original publication is properly cited, the use is noncommercial (i.e., research or educational use), and no modifications or adaptations are made. See: https://creativecommons.org/licenses/by-nc-nd/4.0/

PMC Copyright notice

Figure 2: — Modelled monkeypox virus (MPXV) cumulative infections and incidence rate in 2 cities under 3 different vaccine allocation scenarios. Gray bar indicates the period of vaccine roll-out (days 45–75). City A reflects a Toronto-like city and city B reflects a medium-sized city in Ontario. For vaccine allocation, proportional allocation (to city size) was 75% to city A and 25% to city B, and optimal allocation (most infections averted by day 90) was 100% to city A. Note: Risk = risk of MPXV infection or transmission, defined by numbers of sexual partners (definitions in Appendix 1, available at www.cmaj.ca/lookup/doi/10.1503/cmaj.221232/tab-related-content).